Preclinical Studies in Drug Development Testing and Studies

Design and Plan Clinically-Focused Studies

Fast-track your research with an integrative suite of preclinical tools built around cellular pathway interrogation, combination strategies and mutational context identification to inform clinical development plans.

As an AAALAC-accredited facility, TD2 focuses heavily on the highest level of quality in all areas of research. Clients have access to preclinical resources, tools and more than 300 human and murine models, including:

• Non-GLP safety/tolerability
• In vitro assays
• DMPK services
• Tumor xenograft models
• Patient-derived tumor xenograft models
• Syngeneic tumor models
• Orthotopic tumor models

Molecular Science and Agent Efficacy

We support projects involving all types of molecules, including small molecules and biologics (cell-based therapies, ADCs, vaccines, immunoconjugates, peptides, antibodies, siRNAs and miRNAs), and execute studies to demonstrate efficacy in both single agent and combination settings.

Dedicated Project Managers

Keep work running smoothly with expert project managers who stay with your program from start to finish, can quickly faciliate mid-study changes, and are available for any questions within a 24-hour response window. Flexibility is key to a successful study outcome and that is a hallmark of TD2's service.

Need help with your model selection? Contact TD2 to get more information about our murine models available for immediate use.

Contact Us Now
You may also be interested in
Preclinical Many Drugs Don’t Move Past Phase I. Will Yours? Read the Post Preclinical Will Your Cancer Drug Move Past Phase 1? Read the Post Preclinical The Missing Step Between Phase I and Phase II Read the Post